Grail

News

Commission can rule on Illumina, Grail merger, says EU court

Illumina's attempt to prevent the European Commission from carrying out an antitrust review of its $8 billion takeover last year of cancer diagnosis firm Grail has been defeated in an EU co

R&D

Early detection of cancers will require blood sweat and tear...

An NHS study of a new cancer blood test holds huge promise, but will not be without its challenges, says Snedden Campbell’s Ivor Campbell.

News

NHS England starts largest ever trial of Galleri cancer bloo...

A blood test called Galleri that could detect dozens of different forms of cancer before symptoms appear will start trials by the NHS in England involving around 140,000 subjects.<

News

Illumina wants to bring liquid biopsy spinout Grail back in-...

Cancer diagnosis firm Grail could be re-joining Illumina, the company it was spun out of in 2016, despite filing for an initial public offering (IPO) just a few days ago.

News

Cancer blood test firm Grail mulls IPO

Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.

News